Article
Discovering and Validating Neoantigens by Mass Spectrometry-based Immunopeptidomics and Deep Learning
2022-07-05
Abstract excerpt
Neoantigens are promising targets for cancer immunotherapy but their discovery remains challenging, mainly due to the sensitivity of current technologies to detect them and the specificity of our immune system to recognize them. In this study, we addressed both of those problems and proposed a new approach for neoantigen identification and validation from mass spectrometry (MS) based immunopeptidomics. In particul...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 37dade20-2fe0-5510-bab8-0b9731f1d92f
- DOI
- 10.1101/2022.07.05.497667
